98 related articles for article (PubMed ID: 3515660)
21. Functional assessment of immune markers of graft rejection: a comprehensive study in live-related donor renal transplantation.
Panigrahi A; Deka R; Bhowmik D; Dash SC; Tiwari SC; Guleria S; Mehta SN; Mehra NK
Clin Transplant; 2006; 20(1):85-90. PubMed ID: 16556160
[TBL] [Abstract][Full Text] [Related]
22. The effects of immunomodulation on peripheral T cell subsets.
Chatenoud L; Berrih S; Bene MC; Kreis H; Bach JF
J Clin Immunol; 1982 Jul; 2(3 Suppl):61S-66S. PubMed ID: 6290529
[TBL] [Abstract][Full Text] [Related]
23. Interstitial mononuclear cell populations in renal graft rejection. Identification by monoclonal antibodies in tissue sections.
Platt JL; LeBien TW; Michael AF
J Exp Med; 1982 Jan; 155(1):17-30. PubMed ID: 7033436
[TBL] [Abstract][Full Text] [Related]
24. Humoral immunity in renal transplantation Detection of cytotoxic antibodies to lymphocyte antigens other than HLA-A,B,C and Ia-like antigens in patients with vascular graft rejection.
Lordon RE; Wilson RL; Shield CF; Ferrone S
Transplantation; 1981 Oct; 32(4):286-90. PubMed ID: 7036445
[TBL] [Abstract][Full Text] [Related]
25. T11+/DR+ lymphocytes in renal allograft recipients with irreversible rejection.
Hayes JM; Valenzuela R; Novick AC; Steinmuller DR
Transplantation; 1988 Apr; 45(4):806-9. PubMed ID: 2895969
[No Abstract] [Full Text] [Related]
26. Anti-HLA antibodies in kidney transplanted patients.
Maccarone D; Cervelli C; Parzanese I; Pisani F; Caniglia L; Rascente M; Battistoni C; Famulari A; Adorno D
Transplant Proc; 2005; 37(6):2459-60. PubMed ID: 16182708
[TBL] [Abstract][Full Text] [Related]
27. Relevance of posttransplant flow cytometric T- and B-cell crossmatches in tacrolimus-treated renal transplant patients.
Lenaers JI; Christiaans MH; Voorter CE; van Hooff HP; van den Berg-Loonen EM
Transplantation; 2006 Nov; 82(9):1142-7. PubMed ID: 17102764
[TBL] [Abstract][Full Text] [Related]
28. Allosensitization to HLA and MICA is an important measure of renal graft outcome.
Panigrahi A; Siddiqui JA; Rai A; Margoob A; Khaira A; Bhowmik D; Tiwari SC; Guleria S; Mehra NK
Clin Transpl; 2007; ():211-7. PubMed ID: 18637472
[TBL] [Abstract][Full Text] [Related]
29. Reappraisal of HLA antibody analysis and crossmatching in kidney transplantation.
Lee PC; Ozawa M
Clin Transpl; 2007; ():219-26. PubMed ID: 18642453
[TBL] [Abstract][Full Text] [Related]
30. Characterization of B-cell and monocyte antibodies in recipient sera and in eluates from rejected kidney allografts.
Nunez G; McPhaul J; Stastny P
Transplant Proc; 1981 Mar; 13(1 Pt 1):111-3. PubMed ID: 7022807
[TBL] [Abstract][Full Text] [Related]
31. Absence of irreversible rejection in the presence of warm anti-donor-HLA class I cytotoxic IgG antibody.
Shoker A; Klassen J; Herbut B
Clin Nephrol; 1997 Feb; 47(2):87-91. PubMed ID: 9049455
[TBL] [Abstract][Full Text] [Related]
32. [Present and future value of monoclonal antibodies in nephrology].
Rothschild E; Chatenoud L; Bach JF
Presse Med; 1985 Oct; 14(35):1833-8. PubMed ID: 2933669
[TBL] [Abstract][Full Text] [Related]
33. Frequency and clinical implications of development of donor-specific and non-donor-specific HLA antibodies after kidney transplantation.
Hourmant M; Cesbron-Gautier A; Terasaki PI; Mizutani K; Moreau A; Meurette A; Dantal J; Giral M; Blancho G; Cantarovich D; Karam G; Follea G; Soulillou JP; Bignon JD
J Am Soc Nephrol; 2005 Sep; 16(9):2804-12. PubMed ID: 16014742
[TBL] [Abstract][Full Text] [Related]
34. The association among C4d staining in renal transplant biopsies, the production of donor-specific HLA antibodies, and graft outcome.
Howie AJ
Transplantation; 2007 Feb; 83(4):373-4. PubMed ID: 17318067
[No Abstract] [Full Text] [Related]
35. Monitoring of anti-HLA and anti-Major histocompatibility complex class I related chain A antibodies in living related renal donor transplantation.
Panigrahi A; Gupta N; Siddiqui JA; Margoob A; Bhowmik D; Guleria S; Mehra NK
Transplant Proc; 2007 Apr; 39(3):759-60. PubMed ID: 17445592
[TBL] [Abstract][Full Text] [Related]
36. Immunobiology of transplant rejection.
Häyry P
Ann Clin Res; 1981; 13(4-5):172-98. PubMed ID: 7039479
[No Abstract] [Full Text] [Related]
37. Stable T-cell reactivity after successful tapering of azathioprine in HLA-identical living-related kidney transplant recipients despite minor histocompatibility antigen mismatches.
Gerrits JH; van de Wetering J; Postma S; Drabbels JJ; Vaessen LM; IJzermans JN; Rischen J; Claas FH; Weimar W; van Besouw NM
Nephrol Dial Transplant; 2007 Feb; 22(2):353-61. PubMed ID: 17124279
[TBL] [Abstract][Full Text] [Related]
38. Renal interstitial cell populations in cyclosporine nephrotoxicity. Identification using monoclonal antibodies.
Platt JL; Ferguson RM; Sibley RK; Gajl-Peczalska KJ; Michael AF
Transplantation; 1983 Sep; 36(3):343-6. PubMed ID: 6351377
[No Abstract] [Full Text] [Related]
39. De novo anti-HLA antibody responses after renal transplantation: detection and clinical impact.
Seveso M; Bosio E; Ancona E; Cozzi E
Contrib Nephrol; 2009; 162():87-98. PubMed ID: 19001816
[TBL] [Abstract][Full Text] [Related]
40. T cell subsets in renal transplanted patients defined by theophylline sensitivity and monoclonal antibodies.
Shapira Z; Shohat B; Yussim A; Shmueli D; Servadio C
Proc Eur Dial Transplant Assoc Eur Ren Assoc; 1985; 21():1037-41. PubMed ID: 3887371
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
